News | November 08, 2024
Neuland Laboratories Q2 FY25 consolidated PAT falls to Rs. 32.84 Cr
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
The inspections concluded with no Form 483 observations or significant critical findings
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Cipla has received 8 inspectional observations in Form 483
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
Subscribe To Our Newsletter & Stay Updated
